ITEMS IN AFP WITH KEYWORD:
Colorectal cancer causes significant morbidity and mortality in the United States. The incidence of colorectal cancer can be reduced with increasing efforts directed at mass screening of average-risk adults 50 years and older. Currently, fecal occult blood test and flexible sigmoidoscopy have the hi...
This article describes a joint update of guidelines by the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer delineating evidence-based surveillance recommendations for patients after polypectomy and colorectal cancer resection. Although there are some qualifying con...
Jul 1, 2007 Issue
Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on routine aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) for the primary prevention of colorectal cancer and the supporting scientific evidence.
Jun 1, 2007 Issue
Fecal Occult Blood Tests Reduce Colorectal Cancer Mortality [Cochrane for Clinicians]
Fecal occult blood testing reduces colorectal cancer mortality by 16 percent. Annual testing and rehydration of samples increases testing sensitivity but also increases the number of false-positive results.
Sep 15, 2006 Issue
CDC Recommends Increased Awareness for Colorectal Screening [Practice Guidelines]
The CDC recommends continued measures to encourage screening to reduce mortality rates from colorectal cancer. The Centers for Disease Control and Prevention (CDC) has compared data from the 2002 and 2004 Behavioral Risk Factor Surveillance System (BRFSS) surveys to determine the number of persons r...
Combined evidence from two clinical trials of calcium supplementation lasting for several years revealed a reduced rate of recurrent colorectal adenoma. However, evidence is insufficient to recommend supplementation with dietary calcium for patients who have never had an adenoma.
Case study: MB is a 51-year-old woman who visits you for a refill of her antihypertensive medication. Noticing that she has not been screened for colorectal cancer, you inquire about her family history and conduct a pertinent review of systems, both of which are unremarkable.
Dec 15, 2002 Issue
Screening for Colorectal Cancer: Recommendation and Rationale [U.S. Preventive Services Task Force]
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for colorectal cancer and the supporting scientific evidence, and it updates the 1996 recommendations contained in the Guide to Clinical Preventive Services, Second Edition.
Colorectal cancer is a significant contributor to morbidity and mortality in the United States. Studies published in the early 1990s, showing that screening for colorectal cancer can reduce colorectal cancer-related mortality, led many organizations to recommend screening in asymptomatic, average-ri...